Novartis Investigative Site

Zwijndrecht NL-3331 LZ

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Chronic Plaque Type Psoriasis, Familial Hypercholesterolemia, Symptomatic Atherosclerosis, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early